The Revised International Prognostic Scoring System (IPSS-R) is not Predictive of Survival in Patients with Secondary Myelodysplastic Syndromes
|
Apr 2015
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes
|
Mar 2015
|
Blood Cancer J
|
myelodysplastic syndromes (MDS)
|
The Race for Survival in Myelodysplastic Syndromes
|
Sep 2012
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion
|
Oct 2019
|
Annals of Hematology
|
myelodysplastic syndromes (MDS)
|
The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes
|
Nov 2016
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
The prognostic value of serum c-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes
|
Aug 2016
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
The Problem of TP53-Mutant MDS/AML
|
Sep 2020
|
Clinical Lymphoma , Myeloma & Leukemia
|
acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
|
The phenotype of a germline mutation in PIGA: the gene somatically mutated in paroxysmal nocturnal hemoglobinuria
|
Feb 2012
|
Am J Hum Genet
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
The Non-transplant Treatment of Myelodysplastic Syndromes-What's on the Horizon?
|
Oct 2012
|
Semin Hematol
|
myelodysplastic syndromes (MDS)
|
The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes
|
May 2019
|
Leukemia & Lymphoma
|
myelodysplastic syndromes (MDS)
|